TIAA CREF Investment Management’s Repros Therapeutics Inc. RPRX Stock Holding History

TIAA CREF Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-51,322	Closed	-$367K	–	3279
2015 Q2	$367K	Sell	51,322 -87,331	-63%	-$680K	﹤0.01%	3036
2015 Q1	$1.19M	Buy	138,653 +11,842	+9%	+$106K	﹤0.01%	2524
2014 Q4	$1.26M	Buy	126,811 +28,726	+29%	+$245K	﹤0.01%	2526
2014 Q3	$971K	Sell	98,085 -1,744	-2%	-$25.8K	﹤0.01%	2641
2014 Q2	$1.73M	Sell	99,829 -1,046	-1%	-$17.1K	﹤0.01%	2390
2014 Q1	$1.79M	Buy	100,875 +12,355	+14%	+$239K	﹤0.01%	2301
2013 Q4	$1.62M	Sell	88,520 -1,103	-1%	-$20.8K	﹤0.01%	2373
2013 Q3	$2.4M	Buy	89,623 +13,547	+18%	+$290K	﹤0.01%	2094
2013 Q2	$1.4M	Buy	+76,076	New	+$1.34M	﹤0.01%	2369

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DCM

Destrier Capital Management New York $144M AUM 7.28% 1-Year Est. Return

TIAA CREF Investment Management's RPRX Position: Q3 2015 in Review

TIAA CREF Investment Management sold out of Repros Therapeutics Inc. (RPRX) in Q3 2015, closing a stake of 51,322 shares — an estimated $367K sold.

TIAA CREF Investment Management first reported a position in RPRX in Q2 2013 and held it in 9 quarters. The position peaked at $2.4M in Q3 2013. 58 funds tracked by Wall St. Rank hold RPRX as of Q3 2015.

TIAA CREF Investment Management reported no remaining Repros Therapeutics Inc. position as of Q3 2015 after selling out during the quarter.
TIAA CREF Investment Management sold 51,322 Repros Therapeutics Inc. shares in Q3 2015, an estimated $367K.
TIAA CREF Investment Management first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 9 quarters.
TIAA CREF Investment Management's Repros Therapeutics Inc. position peaked at $2.4M in Q3 2013.
58 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q3 2015.

Based on TIAA CREF Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.